Skip to main content

Advertisement

Log in

Retinoid Therapy for Acne

A Comparative Review

  • Therapy In Practice
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Retinoids play a vital role in the treatment of acne because they act on the primary lesion, the microcomedo. They are synthetic derivatives of vitamin A (retinol), and are selected for their effectiveness. Several compounds are used for acne, either in topical or systemic form.

We describe and compare the different topical retinoids, tretinoin (all-trans-retinoic acid), isotretinoin (13-cis-retinoic acid), adapalene (derived from naphthoic acid), and tazarotene (acetylenic retinoid). They act mainly as comedolytics, but anti-inflammatory actions have also been discovered recently. The retinoids have great beneficial effects, but also some adverse effects, the main one being teratogenicity. It is preferable not to use them in topical form for pregnant women, although a pregnancy test is only compulsory for tazarotene.

Only isotretinoin is used in systemic form. It acts on all the factors of acne and offers long remissions, and sometimes complete cures. Precautions must be taken for women of childbearing age due to its teratogenicity. It is also important to be aware of its other adverse effects, explain them to the patient and, if possible, deal with them in advance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

Similar content being viewed by others

References

  1. Elder JT, Fischer GJ, Zhang O, et al. Retinoic acid gene receptor expression in human skin. J Invest Dermatol. 1991; 96: 425–33

    Article  CAS  PubMed  Google Scholar 

  2. Galvin SA, Gilbert R, Baker M, et al. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol 1998; 139 Suppl. 52: 34–40

    Article  CAS  PubMed  Google Scholar 

  3. Nyirady J, Nihland M, Payonk G, et al. A comparative evaluation of tretinoin gel microsphere, versus tretinoin cream 0,025% in reducing facial shine. Cutis 2000 Aug; 66 (2): 153–6

    CAS  PubMed  Google Scholar 

  4. Leyden JL. Emerging topical retinoid therapies. J Am Acad Dermatol. 1998; 38: S1–4

    Article  CAS  PubMed  Google Scholar 

  5. Cunliffe W, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomised trials. Br J Dermatol. 1998; 139: 48–56

    Article  CAS  PubMed  Google Scholar 

  6. Thiboutot D, Gold M, Jarrat M, et al. Randomized controlled trial of the tolerability, safety and efficacy of adapalene gel 0.1% and tretinoin micro sphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001; 68: 10–9

    CAS  PubMed  Google Scholar 

  7. Cunliffe W, Damby W, Dunlap F, et al. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.01% and tretinoin cream 0.05% in patients with acne vulgaris. Eur J Dermatol. 2002; 12: 350–4

    CAS  PubMed  Google Scholar 

  8. Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001; 68: 48–54

    CAS  PubMed  Google Scholar 

  9. Guenther LC. Optimizing treatment with topical tazarotene. Am J Clin Dermatol 2003; 4(3): 197–202

    Article  PubMed  Google Scholar 

  10. Dominguez J, Hojyo MT, Celayo JL, et al. Topical isotretinoin vs topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol. 1998 Jan; 37 (1): 54–5

    Article  CAS  PubMed  Google Scholar 

  11. Michel S, Jomard A, Demarchez M. Pharmacology of adapalene. Br J Dermatol. 1998; 139: 3–7

    Article  CAS  PubMed  Google Scholar 

  12. Shalita A, Weiss JS, Chalker DK, et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J Am Acad Dermat. 1996; 34: 482–5

    Article  CAS  Google Scholar 

  13. Wolff JE. Potential anti-inflammatory effects of topical retinoids and retinoid analogues. Adv Ther. 2002; 19: 109–18

    Article  Google Scholar 

  14. Bershad S, Kranjac Singer G, Parente JE, et al. Successful treatment of acne vulgaris using a new method: results of a randomized-vehicle control trial of short contact therapy with 0.1 tazarotene gel. Arch Dermatol. 2002 Apr; 138 (4): 481–9

    Article  CAS  PubMed  Google Scholar 

  15. Bershad S, Poulin YP, Berson DS, et al. Topical retinoids in the treatment of acne vulgaris. Cutis. 1999 Aug; 64(2 Suppl.): 8–20

    CAS  PubMed  Google Scholar 

  16. Bershad S. Development in topical retinoid therapy for acne. Semin Cutan Med Surg. 2001 Sep; 20 (3): 154–61

    Article  CAS  PubMed  Google Scholar 

  17. Peck GL, Olsen TG, Yoder FW, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med. 1979 Feb 15; 300 (7): 329–33

    Article  CAS  PubMed  Google Scholar 

  18. Blaner WS. Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol. 2001; 45: S129–35

    Article  CAS  PubMed  Google Scholar 

  19. Strauss JS, Leyden JJ, Lucky AW, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001; 45: 187–95

    Article  CAS  PubMed  Google Scholar 

  20. Geiger JM, Hommel L, Harms M, et al. Oral 13-cis-retinoic acid is superior to 9-cis retinoic acid in sebosuppression in human beings. J Am Acad Dermatol. 1996; 36: 513–5

    Article  Google Scholar 

  21. Cunliffe WJ, Norris JFB. Isotretinoin: an explanation for its long term benefit. Dermatologica:. 1987; 175 Suppl. 1: 133–7

    Article  PubMed  Google Scholar 

  22. Strauss JS, Leyden JJ, Lucky AW, et al. Safety of a new micronized formulation of isotretinoin in patients with severe nodular acne: a randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol. 2001; 45: 196–207

    Article  CAS  PubMed  Google Scholar 

  23. Chivot M. Residual acne lesions after treatment. Ann Dermatol Venereol. 1996; 123 (9): 594–600

    CAS  PubMed  Google Scholar 

  24. Wisowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol. 2002; 46 (4): 505–9

    Article  Google Scholar 

  25. Milstone ML, Guire MC, Ablow RC. Premature epiphysal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol. 1982; 7: 663–6

    Article  CAS  PubMed  Google Scholar 

  26. Marini JC, Hill S, Zasloff MA. Dense metaphysal bands and growth arrest associated with isotretinoin therapy. Am J Dis Child. 1988; 142 (3): 316–8

    CAS  PubMed  Google Scholar 

  27. Nishimura G, Mugishima H, Hirao J, et al. Generalised metaphysal modification with cone-shaped epiphyses following long-term administration of 13-cis retinoic acid. Eur J Pediatr. 1997; 156: 432–5

    Article  CAS  PubMed  Google Scholar 

  28. Chivot M. Acne flare-up and deterioration with oral isotretinoin. Ann Dermatol Venereol. 2001; 128: 224–8

    CAS  PubMed  Google Scholar 

  29. Macdonald-Hull S, Cunliffe WJ. The safety of isotretinoin in patients with systemic diseases. J Dermatol Treat. 1989; 1: 35–7

    Article  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martine Chivot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chivot, M. Retinoid Therapy for Acne. Am J Clin Dermatol 6, 13–19 (2005). https://doi.org/10.2165/00128071-200506010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200506010-00002

Keywords

Navigation